DR. FAHMI FARAH – IVERMECTIN FOR COVID-19 2 20 21

DR. FAHMI FARAH – IVERMECTIN FOR COVID-19 2 20 21

Ever wondered if a common anti-parasitic drug could hold the key to treating COVID-19? Dr. Fahmi Farah, a cardiologist at Baylor-Scott-White and Texas Health Hospitals, joins the hosts of 'American Medicine Today' to shed light on this intriguing possibility. In this episode, Dr. Farah explores the potential of ivermectin, a medication typically used for parasitic infections like scabies, in alleviating COVID-19 symptoms.

She explains how, at a cellular level, ivermectin may inhibit the virus's ability to replicate by interfering with protein binding and transport within cells. However, she also stresses that while initial lab studies show promise, large-scale human trials are still needed to confirm its effectiveness. Beyond ivermectin, Dr. Farah discusses other treatments that have shown success against COVID-19, such as remdesivir, convalescent plasma, monoclonal antibodies, and dexamethasone.

The conversation takes a critical turn as they address the politicization of drugs during the pandemic, highlighting the necessity of rigorous scientific research over political influence. This episode is packed with valuable insights into the ongoing search for effective COVID-19 treatments and underscores the importance of science-led approaches in battling the virus.